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A CASE OF CONSECUTIVE LYMPHOMAS
A G M Martin, T C M Morris
Haematology Department, Belfast City Hospital
A 33 year old male had an acute septic episode
resultinginmulti-organfailure anddeath. Atage
13 he was diagnosed with lymphocyte
predominantHodgkin'sdiseaseofcervicalnodes
and treated with localised radiotherapy. This
diagnosis was confirmed retrospectively by
immunocytochemistry which showed the sparse
large mononuclear cells to be CD15 -ve, CD 30
-ve and CD 20 +ve. He remained well and in
remission until he was 30 years of age when he
developed diffuse large B cell lymphoma (CD20
+ve, CD 3 -ve, CD30 -ve, CD15 -ve) of
abdominal nodes. He received 6 courses of
conventionalCHOPchemotherapy andagainhad
acompleteremissionwhichlastedforthreeyears.
A tissue diagnosis during his acute presentation
proved elusive. However at postmortem
examination a widespread large cell lymphoma
of T cell type (CD3 +ve, CD20 -ve) with
involvement of liver, lymph nodes and bone
marrow. Ki-67 was >50%. Second lymphomas
followingHDarewelldocumented, butonreview
of the literature we could find no case reports
corresponding to the number and type of
lymphomas which occurred in this patient.
Immunoglobulin and T gene rearrangement
studies of the diagnostic material from all three
presentations are in progress.
AMYLOIDOSIS: SYSTEMIC OR LOCAL
S Hegarty, C O'Keane
Department of Pathology, Mater Misericordiae Hospital,
Eccles Street, Dublin 7
Amyloidosis is a disorder of protein folding in
whichnormally soluble proteins aredeposited as
insoluble fibrils, disrupting organ function and
causing disease. The deposited proteins may
involveonesingleorgansystemorbewidespread
throughout the body. We present a case of
laryngeal amyloidosis in a 62 year old man, and
review the current literature on diagnosis and
treatmentofthisunusualdisease, withdiscussion
of the difficulties in determining whether the
diseaseislocalorsystemic. Laryngealamyloidis
reported in 100 cases in current literature, and
presents difficulties in diagnosis and therapy.
AORTIC VALVE PAPILLARY FIBROELASTOMA
IN A PATIENT WITH AN INCIDENTAL FINDING
OF BRADYCARDIA
C J O'Neill, M Y Walsh
InstituteofPathology, RoyalVictoriaHospital, Grosvenor
Road, Belfast BT12 6BA.
Wepresentapatientwho,followinginvestigation
for asymptomatic, incidental bradycardia, was
demonstrated to have a papillary fibroelastoma
on his aortic valve.
The microscopic appearance ofthe lesion was of
papilliform projections arising from the valve.
They featuredacentralcore, comprisedofdense,
paucicellular collagen with a varying degree of
myxomatous matrix, lined by a surface layer of
endothelial cells. The appearances were those of
a papillary fibroelastoma, which is a relatively
rarelesion: by 1991 only 132caseshadbeencited
in the literature.' However, ifbenign tumours of
the heart are considered, they rank third in the
adult population.2 Constituting 11.6% of all
histologically benign tumours. A synopsis of
knowledge regarding papillary fibroelastomata
will be given including site of involvement, age
and sex predilection, histogenesis, main
differential diagnoses and clinical sequelae.
1. Burke A, Virmani R. Tumours of the heart and great
vessels. Atlas of tumour Pathology. Third Series,
Fascicle 16. Armed Forces of The Institute of
Pathology. Washington DC 1996.
2. Rubin M A, Snell J A, Tazelnaar H D, Lack E E,
Austenfeld J L, Azumi N. Cardiac papillary
fibroelastoma: animmunohistochemicalinvestigation
andunusualclinicalmanifestations.ModPathol 1995;
8(4): 402-7.
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3. Amr S S, Abu al Ragheb S Y. Sudden unexpected
death due to papillary fibroma of the aortic valve.
Report of a case and review of the literature. Am J
Forensic Med Pathol 1991; 12(2): 143-8.
CORRELATION OF PROSTATE NEEDLE
BIOPSIES WITH PROSTATE-SPECIFIC
ANTIGEN
Tunde Agedbola,l Olubunmi Ipadeola,' John Callaghan.'
Helen Grimes.2
DepartmentofHistopathology' andClinicalBiochemistry,2
University College Hospital, Galway.
ABSTRACT
Introduction:
Prostate specific antigen has proven to be a good
screening instrument for prostate cancer, which
is the second leading cause of cancer death in
males. Poor specificity and low predictive value
have been some of the reported limitations.
Objectives:
To correlate the histopathological findings in
Prostatic needle biopsies with level oftotal PSA
and ratio of free to total PSA and to determine
sensitivity, specificity and positive predictive
value at different cut off levels.
Materials and Methods:
Prostate corebiopsies received inthe department
of histopathology between 2001 and 2002 were
retrieved from file and reviewed. All patients
with available PSA results were included in the
study. All patients have sextant biopsies, which
were processed routinely.
Result:
187 patients were studied, mean age 71 years. 88
were benign and 99 malignant with mean age of
68 and 73 respectively. There was significant
relationship between elevated total PSA and low
PSA ratio and malignancy (P<0.5). We found
optimal cut off value for total PSA to be lOng/l
with sensitivity and specificity of 70% and 72%
respectively andpositivepredictivevalueof73%.
The sensitivity rises to 96% but the specificity
drop to 17% with positive predictive value of
57%atcutofvalueof4ng/1.Thereisnosignificant
improvement in sensitivity at cut off value of
2ng/l. The optimal cut off for PSA ratio is 10%
with sensitivity and specificity 53% and 79%
respectivelyandpositivepredictivevalueof62%.
PSAratio is found to beuseful in whentotal PSA
fall in the grey zone of 4-lOng/l for optimal
result.
Conclusion:
Both total PSA and PSA ratio are useful in
screening forprostate cancer. Total PSA should
form the main anchor in making decisions.
CUTANEOUS MALIGNANT MELANOMA IN
YOUNG PATIENTS UNDER 21 YEARS IN
NORTHERN IRELAND - AN 18 YEAR
RETROSPECTIVE REVIEW
V Phillips, M Walsh.
Department of Pathology, Royal Group of Hospitals,
Belfast.
Malignantmelanomaisararetumourinchildhood
and adolescence but some studies have shown an
increaseinincidence overthelast20yearswhich
is felt to be independent of earlier clinical
detection. Previouslythemajorityoftheselesions
in childhood were thought to arise in congenital
naevi but recent reports have highlighted new
risk factors.
The hospital notes of patients aged under 21
years with a histological diagnosis ofmelanoma
(n=20) were retrieved from the files of the
department of pathology in the Royal Group of
Hospitals, from January 1984 to December 2002
inclusive.Thehistologicalsectionswerereviewed
by both authors to confirm the diagnosis.
The age ofthepatientsrangedbetween 13 and 20
years with a mean age of 18 years. No cases in
childrenunder 12years werepresentinthestudy.
55% (11 cases) were female with a mean age of
18 years and 45% (9 cases) were male; mean age
17 years. The majority were located on the upper
limbs (30%) and head and neck (25%) with 20%
involvement of the lower limb. Approximately
15% involvedthetrunkandbackandintwocases
(10%) no site was given. In 12 of 20 cases the
histogenic type was superficial spreading
melanoma, four were nodular, three were
melanomainsituandonerepresentedarecurrence
in a scar with noprevious histology available for
review. The majority (94%) were of epithelioid
cell type with one ofspindle cell type. Breslow's
depth ranged from 0.1mm to 1.6cm with a mean
of 2.4mm. 50% were Clarke level IV at
presentation. Eight of20 cases presented atpTI,
6 cases pT2.,3 cases pT4,2 cases pTis and 1 case
pTO.
In 30% of cases (6) a co-existing benign
intradermal/congenital naevus was identified.
C The Ulster Medical Society, 2003.
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While malignant melanoma in young people
remainsarelativelyunusualtumourtheincidence
of melanoma is rising in the general population
and the incidence in teenagers is also increasing.
While numbers are small pathologists need to be
aware that melanomas do occur in teenagers and
young adults.
AN UNUSUAL CAUSE OF DELAYED RUPTURE
OF SPLEEN
A Ammar, J Callaghan
Department of Histopathology, University College
Hospital, Galway.
Splenic trauma is a rare fatal complication of
colonoscopy. Awareness ofthis complication is
essential for early diagnosis and management.
We report a case of rupture of the spleen seven
daysfollowingcolonoscopy. A72yearoldfemale
presented with recent onset of weight loss and
anaemia. Colonoscopy was carried out amongst
other investigations to exclude malignancy. No
abnormality was found. Two days following this
procedure her haemoglobulin level fell,
necessitating blood transfusion. The patient
developed severeleftloinpainwithtenderness in
the left iliac fossa on day seven following
colonoscopy. The clinical impression was of
possible intestinal obstruction or intestinal
ischaemia. Plain X-Ray ofthe abdomen showed
distension of the bowel. She developed sudden
cardiopulmonary arrestandresuscitation wasnot
successful. A post-mortem examination was
carried out. The relevant pathological findings
were of rupture of the spleen with associated
haemorrhage and fresh blood clot.
Microscopically, there was associated abundant
ironpigment. The relevance ofthis inrelation to
recent haemorrhage is discussed.
CUTANEOUS NODULAR AMYLOIDOSIS - A 12
YEAR REVIEW
C J O'Neill, M Y Walsh
Institute of Pathology, Royal Group of Hospitals,
Grosvenor Road, Belfast BT12 6BA.
Amyloidosis is ageneric termdescribing agroup
of diseases, of both localized and systemic
distribution, in which there is deposition of
fibrillary proteins having a B-pleated sheet
configurationonX-raycrystallography.' Nodular
amyloidosis is an uncommon pattern ofamyloid
distribution,thoughttobeduetolocalizedplasma
cell dyscrasias.2'3 Records over a 12 year period
(totalling 234,803) were reviewed: five patients
hadbeen diagnosed as having cutaneous nodular
amyloidosis duringthisperiod. Theaffectedsites
were predominantly in the head and neck.
Importantly, the histopathological appearances
cannot be distinguished from those of systemic
amyloidosis and consequently in all cases
encountered the clinicians shouldberemindedto
give consideration to the possibility of systemic
disease, specifically multiple myeloma.4 Skin
lesions are detected in approximately 30% of
patients with systemic amyloidosis.5
1. Kakani R S, Goldstein A E, Meisher I, Hoffman C.
Nodular amyloidosis; a case report and literature
review. J Cutan Med Surg 2001; 5(2): 101-4.
2. Helm T E, Danziger J, Helm W F. Bilateral plantar
amyloidosis: a unique presentation of localized
cutaneous amyloidosis. Cutis 1997; 59(3): 142-4.
3. Breathnach S M. Amyloid and amyloidosis. J Am
Acad Dermatol 1988; 18(1 Pt 1): 1-16.
4. McKee P H. Pathology of the skin with clinical
correlations. Philadelphia: J B Lippincott 1992.
p. 7.11-7.16.
5. Alexanian R, Fraschini G, Smith L: Amyloidosis in
multiple myeloma or without apparent cause. Arch
Intern Med 1984; 144(11): 2158-60.
ENDOMETRIAL ADENOCARCINOMA ON A
BACKGROUND OF MIRENA COIL INSERTION
E Doyle, M Foley, P Lenehan, G Flannelly, P Kelehan, E
E Mooney
Departments of Histopathology and Gynaecology, The
National Maternity Hospital, Holles Street, Dublin 2.
We present the case histories of 3 patients who
had a Mirena coil in situ at the time ofdiagnosis
of endometrial adenocarcinoma. Two
premenopausal women (48-49 years), who had
the levonorgestrel intrauterine device inserted
for the treatment of menorrhagia at the time of
curettage, were found to have well differentiated
endometrioid adenocarcinoma. They each
proceededto abdominal hysterectomy withinthe
following 3 months. Both of the resection
specimens showed a well differentiated
endometrioid adenocarcinoma which was
confined to the endometrium. One case showed
focal lymphovascular space invasion while the
otheronehadnoadverseprognostic factors. Both
tumours showedproliferation and mitotic counts
ranging from 3 - 7 per 10 high power fields with
mild to moderate nuclear atypia. The third lady
(36yearsofage)presentedwithmenorrhagiaand
C The Ulster Medical Society, 2003.
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was found at the time ofinitial curettage to have
epithelial hyperplasia that was suspicious of
malignancy. She had a Mirena coil inserted and
repeat curettage 3 months later confirmed the
diagnosis of adenocarcinoma. She proceeded to
hysterectomy within 5 months of her initial
curettage. Theresectionspecimenhadnoresidual
tumour, but was the only specimen to contain
simple hyperplasia. In two ofthe three resection
specimens thebackground endometrium showed
evidence of progesterone effect with stromal
decidual change but gland atrophy was not
identified in any of these cases. These cases
highlight the fact that although the Mirena coil
has helped to revolutionize the treatment of
menorrhagia and has some proven benefit in the
treatment ofhyperplasia, it should notbe used in
the treatment of carcinoma, or relied upon to
prevent the development of carcinoma. It also
highlights theimportance ofproperinvestigation
ofpersistent menorrhagia prior to the instigation
of treatment.
METASTATIC CARCINOMA IN THE SKIN - A 12
YEAR REVIEW
C J. O'Neill, M Y Walsh.
Institute ofPathology, RoyalVictoriaHospital, Grosvenor
Road, Belfast BT12 6BA.
Theskinisanunusualsiteforvisceralmetastases.
It appears to be the eighteenth most frequent site
for carcinomatous metastases.' We reviewed the
incidence of cutaneous metastatic deposits of
visceral metastases over a 12 year period: 47
cases of secondary carcinoma of the skin were
found, the primary site including (in order of
frequency): breast, adenocarcinoma of site
unspecified, gastrointestinal adenocarcinoma,
squamouscell, lung, hepatocellular andprostate.
Theuseandlimitationsofimmunohistochemistry
in the identification oftheprimary source will be
discussed.2Oneofthemaindifferentialdiagnoses
for metastatic adenocarcinoma is cutaneous
adnexal neoplasm. These are often
immunophenotypically similar; consequently
immunohistochemicaltechniquesareoftenunable
to aid in distinguishing between primary and
secondary cutaneous malignancies.3
1. Abrams H L, Spiro R, Goldstein N. Metastases in
carcinoma: analysis of 1000 autopsy cases. Cancer
1950; 3: 74-85.
2. Kende A I, Carr N J, Sobin L H. Expression of
cytokeratins 7 and 20 in carcinomas of the
gastrointestinal tract. Histopathology 2003; 42(2):
137-40.
3. Swanson P E, Mazoujian G, Mills S E, Campbell R J,
Wick M R. Immunoreactivity for estrogen receptor
protein in sweatglandtumours. AmJSurgPath 1991;
15(9): 835-41.
THE ROLE OF IMMUNOHISTOCHEMICAL
EPITHELIAL MARKERS IN THE
HISTOLOGICAL DIAGNOSIS OF
INTRATUBULAR GERM CELL NEOPLASIA
(ITGN)
J McKnight,' B Duggan,' G Lennon,' C Mullholland' and
M Madden2
Departments of Urology' and Pathology,2 Altnagelvin
Area Hospital, Londonderry, Northern Ireland.
Introduction
The significance of ITGN, also known as
carcinoma in situ oftestis, is that50% ofpatients
developed invasive tumours by 5 years. Primary
management is orchidectomy. The aim of the
study was to assess the expression of
immunocytochemicalmarkers-PLAP,CAM5.2,
AEl/AE3, EMA, Vimentin and CD30 and their
use in the histological diagnosis of ITGN.
Methods
The pathology for orchidectomy patients (1995-
2001) wasreviewed andthree groups identified-
normal, or cryptorchid testis and germ cell
tumours. Newtissuesectionswerecutfromstored
blocks and an immunohistochemical panel
examined.
Results
In all groups Vimentin, CD30, AEI/AE3, EMA
and PLAPwere aspreviously published. Ofnote
inthenormal groupCAM5.2stainedtubuleswith
absent spermatogenesis in the substance of the
testis, discrete groups of tubules with absent
spermatogenesis stained in cryptorchid testis,
while CAM5.2 was positive in most tumours.
Conclusion
Our data confirm PLAP is a consistent marker
for ITGN. Of particular interest is the CAM5.2
staining. It is found in tubules with abnormal
spermatogensis both in normal and neoplastic
testes but does not correspond to PLAP positive
ITGN. However there is no proof that CAM5.2
expression in ITGN could predict cells that are
committed towards non-seminomatous
C The Ulster Medical Society, 2003.
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differentiation. CAM5.2 staining pattern most
likely reflects tubular injury.
VIRUSES AND TRANSPLANTATION
K Ramadan, F Jones, M F McMullin.
Haematology Department, Belfast City Hospital, Lisburn
Road, Belfast.
Varicella Zoster virus (VZV) infection is
potentiallyveryseriousinbonemarrowtransplant
recipients, and may manifest as a disseminated
visceral infection. This condition is generally
accompaniedby avesicularrash. Reactivation of
VZV is a common event in patients undergoing
allogeneic bone marrow transplantation (BMT)
and may lead to life-threatening complications.
We describe here a patient who developed acute
abdominal pain eight months post allogeneic
bone transplant carried out for acute myeloid
leukaemia. Gastroscopy revealed multiple,
discrete and haemorrhagic ulcers. The patient
received triple therapy (Lansoprazole,
Amoxicillin and Clarithromycin) without
improvement. Skinrashappeared very late in the
course of the disease. The patient died due to
disseminated varicella-Zoster infection after a
briefadmission to Intensive Care Unit. This rare
presentation of VZV infection is potentially
underdiagnosed. Testing for VZV viraemia by
Polymerase Chain Reaction (PCR) can suggest
thediagnosisalthoughwhetherplasma-associated
viraemia is truly pathognomonic of visceral
disseminatedinfectionremains tobeestablished.
As bacterial infections are becoming less of a
problembecauseofnewandeffectiveantibiotics,
viral infections have emerged as one ofthe main
causes of mortality and morbidity. With fewer
options available to treat severe viral infections,
a need for more effective surveillance and
prevention becomes very clear.
C The Ulster Medical Society, 2003.
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